We are live on ! Find out more
SPWM

Straight Path Wealth Management Portfolio holdings

AUM $428M Turnover 15.07%
1-Year Est. Return 26.3%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+26.3%
3 Year Est. Return
+70.6%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$76.3M
Cap. Flow
+$76.1M
Cap. Flow %
20.51%
Top 10 Hldgs %
65.2%
Holding
146
New
29
Increased
69
Reduced
14
Closed
5
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
2.5 years
Top 20 Avg Time Held Equity + Options
2.1 years
Avg Time Held Equity only
1.6 years
Top 10 Avg Time Held Equity only
2.5 years
Top 20 Avg Time Held Equity only
2.1 years

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$457K
2
WBA icon
Walgreens Boots Alliance
WBA
+$409K
3
BP icon
BP
BP
+$286K
4
PATH icon
UiPath
PATH
+$269K
5
FCTE icon
SMI 3Fourteen Full-Cycle Trend ETF
FCTE
+$227K

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.97%
2 Consumer Discretionary 14.05%
3 Technology 3.31%
4 Energy 1.2%
5 Healthcare 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BND icon
26
Vanguard Total Bond Market
BND
$163B
$2.19M 0.59%
29,421
+284
+1% +$20.9K
2021 Q4
15 quarters
IBHI icon
27
iShares iBonds 2029 Term High Yield and Income ETF
IBHI
$530M
$1.85M 0.5%
77,371
+16,308
+27% +$386K
2023 Q3
8 quarters
IBHE icon
28
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
$1.79M 0.48%
77,183
-1,359
-2% -$31.5K
2023 Q1
10 quarters
IBHJ icon
29
iShares iBonds 2030 Term High Yield and Income ETF
IBHJ
$186M
$1.72M 0.46%
64,273
+12,764
+25% +$339K
2023 Q4
7 quarters
BYRN icon
30
Byrna Technologies
BYRN
$112M
$1.64M 0.44%
+9,000
New +$200K
2025 Q3
0 quarters
PLTR icon
31
CALL
Palantir
PLTR
$445B
$1.64M 0.44%
+9,000
New +$1.46M
2025 Q3
0 quarters
RILY icon
32
PUT
BRC Group Holdings
RILY
$184M
$1.38M 0.37%
+15,000
New +$82.9K
2025 Q3
0 quarters
PFE icon
33
Pfizer
PFE
$168B
$1.38M 0.37%
54,016
-200
-0.4% -$4.94K
2024 Q1
6 quarters
IBHK icon
34
iShares iBonds 2031 Term High Yield and Income ETF
IBHK
$91.4M
$1.37M 0.37%
52,427
+10,315
+24% +$267K
2024 Q4
3 quarters
ALAB icon
35
Astera Labs
ALAB
$49.3B
$1.34M 0.36%
6,850
– –
2025 Q1
2 quarters
HOOD icon
36
Robinhood
HOOD
$87.8B
$1.33M 0.36%
9,295
+3,000
+48% +$327K
2025 Q1
2 quarters
ALAB icon
37
CALL
Astera Labs
ALAB
$49.3B
$1.27M 0.34%
+6,500
New +$1.07M
2025 Q3
0 quarters
PAPR icon
38
Innovator US Equity Power Buffer ETF April
PAPR
$959M
$1.14M 0.31%
29,647
+667
+2% +$25.2K
2023 Q2
9 quarters
BSCW icon
39
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.53B
$1.13M 0.31%
54,270
+16,976
+46% +$352K
2025 Q2
1 quarter
IJUL icon
40
Innovator International Developed Power Buffer ETF July
IJUL
$250M
$1.11M 0.3%
33,987
+740
+2% +$23.8K
2025 Q2
1 quarter
HDV icon
41
iShares Core High Dividend ETF
HDV
$15.6B
$1.1M 0.3%
45,095
+345
+0.8% +$8.34K
2023 Q2
9 quarters
RKLB icon
42
Rocket Lab Corp
RKLB
$32.3B
$1.04M 0.28%
21,700
– –
2023 Q1
10 quarters
BYRN icon
43
CALL
Byrna Technologies
BYRN
$112M
$1.03M 0.28%
+40,500
New +$899K
2025 Q3
0 quarters
PFE icon
44
CALL
Pfizer
PFE
$168B
$1.03M 0.28%
+40,500
New +$1,000K
2025 Q3
0 quarters
ABBV icon
45
AbbVie
ABBV
$505B
$1.01M 0.27%
+4,372
New +$890K
2025 Q3
0 quarters
TEVA icon
46
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
$1.01M 0.27%
50,000
– –
2021 Q4
15 quarters
ARKK icon
47
ARK Innovation ETF
ARKK
$8.44B
$988K 0.27%
11,449
-1,047
-8% -$80K
2021 Q4
15 quarters
CLS icon
48
Celestica
CLS
$38.2B
$982K 0.26%
20,500
+18,150
+772% +$3.66M
2025 Q1
2 quarters
RKLB icon
49
CALL
Rocket Lab Corp
RKLB
$32.3B
$982K 0.26%
+20,500
New +$930K
2025 Q3
0 quarters
PSEP icon
50
Innovator US Equity Power Buffer ETF September
PSEP
$1.22B
$922K 0.25%
21,460
-1,250
-6% -$52.4K
2023 Q4
7 quarters

Similar funds

Straight Path Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Straight Path Wealth Management held 146 positions worth $371M, up 26% from $295M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Straight Path Wealth Management deployed $76.1M of net new capital in Q3 2025, opening 29 new positions and adding to 69 existing holdings. Its largest new stake was AbbVie: 4,372 shares worth $1.01M.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, down from 82% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was BP, an estimated $286K trimmed.

  • Straight Path Wealth Management's largest Q3 2025 buy was AbbVie: 4,372 shares worth $1.01M.
  • Straight Path Wealth Management added most to Meta Platforms (Facebook) in Q3 2025, an estimated $29.8M increase.
  • Straight Path Wealth Management's biggest Q3 2025 reduction was BP, cutting an estimated $286K.
  • Straight Path Wealth Management fully exited 3M in Q3 2025, selling an estimated $457K.
  • Straight Path Wealth Management's ten largest holdings make up 65% of its $371M portfolio in Q3 2025.
  • Straight Path Wealth Management opened 29 new positions and closed 5 in Q3 2025.
  • Straight Path Wealth Management's portfolio value rose 26% quarter-over-quarter to $371M.

Based on Straight Path Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.